Acadia PharmaceuticalsACAD
那斯達克 · USD
22.04
-0.12
(-0.54%)
盤中 03/10 01:58 (UTC+8)
03/10 01:58 (UTC+8)
Acadia PharmaceuticalsACAD
22.04
-0.12
(-0.54%)
財務數據
損益表
- 2.12
- 2.31
- 2.06
- 2.42
- 2.50
- 2.60
- 2.44
- 2.65
- 2.79
- 2.84
- 28.12
- 9.14
- -10.91
- 17.55
- 3.49
- 3.67
- -5.89
- 8.29
- 5.32
- 1.92
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 283,989 | 278,634 | 264,565 | 244,317 | 259,602 | 250,401 | 241,963 | 205,831 | 231,041 | 211,699 |
營業成本 | 26,225 | 21,647 | 20,734 | 20,392 | 21,803 | 18,857 | 18,230 | 22,951 | 17,891 | 14,621 |
營業毛利 | 257,764 | 256,987 | 243,831 | 223,925 | 237,799 | 231,544 | 223,733 | 182,880 | 213,150 | 197,078 |
營業費用 | 240,373 | 221,230 | 211,458 | 204,635 | - | - | 193,296 | - | 178,206 | 254,854 |
研發費用 | 84,757 | 87,829 | 77,951 | 78,265 | 100,731 | 66,606 | 76,233 | 59,679 | 66,741 | 156,963 |
推銷及管理費用 | 155,616 | 133,401 | 133,507 | 126,370 | -16,435 | 133,294 | 117,063 | 107,991 | 111,465 | 97,891 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 17,391 | 35,757 | 32,373 | 19,290 | 153,503 | 31,644 | 30,437 | 15,210 | 34,944 | -57,776 |
其他收入及費用 | 8,928 | 8,838 | 7,838 | 8,489 | 7,582 | 7,162 | 6,745 | 5,792 | 4,759 | 5,633 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 26,319 | 44,595 | 40,211 | 27,779 | 161,085 | 38,806 | 37,182 | 21,002 | 39,703 | -52,143 |
所得稅 | -247,249 | -27,184 | 13,545 | 8,792 | 17,343 | 6,041 | 3,793 | 4,447 | -6,094 | 13,033 |
稅後純益 | 273,568 | 71,779 | 26,666 | 18,987 | 143,742 | 32,765 | 33,389 | 16,555 | 45,797 | -65,176 |
基本每股稅後盈餘(元) | 1.62 | 0.43 | 0.16 | 0.11 | 0.86 | 0.20 | 0.20 | 0.10 | 0.28 | -0.40 |
稀釋每股稅後盈餘(元) | 1.61 | 0.42 | 0.16 | 0.11 | 0.86 | 0.20 | 0.20 | 0.10 | 0.28 | -0.39 |
基本平均股數(千股) | 169335.00 | 168836.00 | 167827.00 | 166808.00 | 166535.00 | 165974.00 | 165551.00 | 164798.00 | 164812.00 | 164234.00 |
稀釋平均股數(千股) | 171359.00 | 170650.00 | 168681.00 | 167668.00 | 166696.00 | 166178.00 | 166174.00 | 166623.00 | 166510.00 | 164234.00 |
還原基本每股稅後盈餘(元) | 1.62 | 0.43 | 0.16 | 0.11 | 0.86 | 0.20 | 0.20 | 0.10 | 0.28 | -0.40 |
還原稀釋每股稅後盈餘(元) | 1.61 | 0.42 | 0.16 | 0.11 | 0.86 | 0.20 | 0.20 | 0.10 | 0.28 | -0.39 |
還原基本平均股數(千股) | 169,335 | 168,836 | 167,827 | 166,808 | 166,535 | 165,974 | 165,551 | 164,798 | 164,812 | 164,234 |
還原稀釋平均股數(千股) | 171,359 | 170,650 | 168,681 | 167,668 | 166,696 | 166,178 | 166,174 | 166,623 | 166,510 | 164,234 |
EBITDA(千元) | 28,573 | 46,443 | 41,610 | 28,614 | 163,482 | 38,629 | 37,799 | 24,744 | 39,561 | -52,416 |